These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4107062)

  • 1. The effects of adrenergic blocking agents on passive cutaneous anaphylaxis reactions in the rat.
    Tolone G; Bonasera L; Bruno R
    Pathol Microbiol (Basel); 1971; 37(3):194-200. PubMed ID: 4107062
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of four types of cutaneous anaphylaxis in the mouse to antihistaminics.
    Harada M; Takeuchi M; Katagiri K
    Int Arch Allergy Appl Immunol; 1968; 34(4):409-16. PubMed ID: 4386788
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of various types of rat cutaneous anaphylaxis from their drug -susceptibilities.
    Harada M; Takeuchi M; Katagiri K
    Dermatologica; 1971; 142(4):193-201. PubMed ID: 4331744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 2-ethyl-3-(4-hydroxybenzoly)-benzofuran (Fragivix) on passive cutaneous anaphylaxis in rats and Arthus reaction in rabbits].
    Yan Kuroyanagi T
    Arerugi; 1969 Jul; 18(7):585-8. PubMed ID: 4243357
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of passive cutaneous anaphylaxis and effects of anti-histaminics on anaphylaxis in guinea pigs].
    Harada M; Takeuchi M; Katagiri K
    Arerugi; 1966 Jan; 15(1):1-7. PubMed ID: 4381228
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of methods of measurements of permeability increases.
    Blum J; Ovary Z
    Int Arch Allergy Appl Immunol; 1974; 46(1):121-7. PubMed ID: 4131020
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergy treatment with a peptide vaccine.
    Stanworth DR; Jones VM; Lewin IV; Nayyar S
    Lancet; 1990 Nov; 336(8726):1279-81. PubMed ID: 1700248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the role of neutrophils in passive cutaneous anaphylaxis of the guinea-pig.
    Taichman NS; Movat HZ; Glynn MF; Broder I
    Immunology; 1971 Oct; 21(4):623-35. PubMed ID: 4107743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of reagin-induced PCA in monkeys by injection of heterologous serum.
    Radermecker M; Goodfriend L; Rose B
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):625-39. PubMed ID: 4992637
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.
    Inagaki N; Miura T; Daikoku M; Nagai H; Koda A
    Pharmacology; 1989; 39(1):19-27. PubMed ID: 2479953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
    Kuriyama K; Hiyama Y; Ito K; Ichikawa K; Kitada S; Yoshinaka I
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):213-24. PubMed ID: 2440785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP; Lauressergues H; Fauran F
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent.
    Azuma H; Banno K; Yoshimura T
    Br J Pharmacol; 1976 Dec; 58(4):483-8. PubMed ID: 63304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemorrhagic reactions elicited at sites of passive cutaneous anaphylaxis by the intravenous injection of aggregated gamma-globulin.
    Bier OG; Passos HC; Siqueira M
    Immunology; 1968 Feb; 14(2):291-8. PubMed ID: 4170890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of quinoline and pyrazolone anti-inflammatory derivatives on passive anaphylaxis in guinea pigs].
    Harada M; Takeuchi M; Katagiri K
    Arerugi; 1966 Jun; 15(6):430-3. PubMed ID: 5963221
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T
    Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.
    Inagaki N; Miura T; Nagai H; Koda A
    Jpn J Pharmacol; 1988 Feb; 46(2):189-92. PubMed ID: 3379829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of hapten-specific antibodies from reagin-rich rat sera and their use for the preparation of rat peritoneal cells for antigen-mediated histamine release.
    Bach MK; Brashler JR; Stechschulte DJ
    Immunochemistry; 1973 May; 10(5):305-11. PubMed ID: 4126035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.